Patient Guide: Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 47 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05037760
Status: 🟢 Enrolling Now
Condition: Myelofibrosis
Phase: PHASE2

Where You Can Participate

This study is available at 47 locations across the country.

Top locations include:
  • • Seattle, Washington
  • • Concord, New South Wales
  • • Tweed Heads, New South Wales
  • • And 44 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis - Join Clinical Trial NCTNCT05037760

How to Join This Clinical Trial - NCTNCT05037760

Learn how to participate in this PHASE2 trial studying an investigational therapy for Myelofibrosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Myelofibrosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Myelofibrosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05037760 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 47 locations. Find a study site near you:

Clinical Research Site

Seattle, Washington 98109 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Concord, New South Wales - Australia

Status: RECRUITING

Clinical Research Site

Tweed Heads, New South Wales 2485 - Australia

Status: RECRUITING

Clinical Research Site

Woodville South, South Australia 5042 - Australia

Status: RECRUITING

Clinical Research Site

Fitzroy, Victoria 3355 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 3050 - Australia

Status: RECRUITING

Clinical Research Site

Wendouree, Victoria 3355 - Australia

Status: RECRUITING

Clinical Research Site

Porto Alegre, - Brazil

Status: RECRUITING

Clinical Research Site

Porto Alegre, - Brazil

Status: RECRUITING

Clinical Research Site

São Paulo, - Brazil

Status: RECRUITING

And 37 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Myelofibrosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships